INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For Respiratory Papillomatosis

RTTNews | 965 วันที่ผ่านมา
INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For  Respiratory Papillomatosis

(RTTNews) - Biotechnology company Inovio Pharmaceuticals Inc. (INO) announced Thursday positive interim results from an ongoing Phase 1/2 clinical trial evaluating INO-3107 for the treatment of HPV 6 and HPV 11-associated Recurrent Respiratory Papillomatosis (RRP) in adults.

In the first cohort of 21 participants, INO-3107 showed a statistically significant improvement in the clinical endpoint of the number of surgical interventions needed to control papilloma growth.

INO-3107 was also observed to be well-tolerated and immunogenic in the trial. INO-3107 received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) in July 2020.

INO-3107 was evaluated in a Phase 1/2 open-label, multicenter trial to assess its safety, tolerability, immunogenicity, and efficacy in 32 participants with HPV 6 and/or HPV 11-associated RRP.

Results from the second cohort of 11 patients are expected in the first half of 2023.

For More Such Health News, visit rttnews.com

แท็ก : INO
read more
Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

Biotechnology company Inovio Pharmaceuticals, Inc. (INO) announced Tuesday that it has received feedback from the U.S. Food and Drug Administration (FDA) that data from its completed Phase 1/2 trial of INO-3107 for the treatment of RRP could support INOVIO's submission of a BLA for review under the FDA's accelerated approval program.
RTTNews | 603 วันที่ผ่านมา
European Economic News Preview: ECB To Cut Interest Rates

European Economic News Preview: ECB To Cut Interest Rates

The European Central Bank is widely expected to cut its interest rates on Thursday after inflation fell below the 2 percent target in May. Markets expect the bank to lower the deposit rate by another 25 basis points to 2.00 percent. The bank has reduced the policy rates by a quarter points each in every rate-setting session since September.
RTTNews | 4 นาทีที่ผ่านมา
Australian Market Slips To Slight Losses In Mid-market

Australian Market Slips To Slight Losses In Mid-market

The Australian market is slipping to slight losses in mid-market moves on Thursday after opening in the green, reversing some of the gains in the previous two sessions, following the mixed cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying below the 8,550 level, with by weakness in energy and financial stocks partially offset gains in iron ore miners and some technology stocks.
RTTNews | 44 นาทีที่ผ่านมา
Asian Markets Trade Mostly Higher

Asian Markets Trade Mostly Higher

Asian stock markets are trading mostly higher on Thursday, following the mixed cues from Wall Street overnight, amid optimism about the outlook for interest rates after the release of some weaker than expected U.S. economic data, which raised concerns about the strength of the economy. Asian markets closed mostly higher on Wednesday.
RTTNews | 1 ชม. 6 นาทีที่ผ่านมา
Sensex, Nifty Set For Muted Start

Sensex, Nifty Set For Muted Start

Indian shares look set to open largely unchanged on Thursday as investors look ahead to the Reserve Bank of India's (RBI) monetary policy decision on June 6, with the central bank widely expected to cut interest rates by 25 basis points for the third consecutive time.
RTTNews | 1 ชม. 38 นาทีที่ผ่านมา